Eli Lilly and Company announced the voting results from its 2026 Annual Meeting of Shareholders held on May 4, 2026. Shareholders elected all four director nominees and approved executive compensation. However, key proposals to declassify the board and eliminate supermajority voting provisions failed to achieve the required 80% approval of all outstanding shares.
Key Details
- Directors Elected: Carolyn Bertozzi, William Kaelin, Jr., Jon Moeller, and David Ricks were elected to serve three-year terms ending in 2029.
- Failed Governance Amendments: Proposals to eliminate the company's classified board structure and to remove supermajority voting provisions did not pass.
- Other Voting Results: Shareholders approved the advisory vote on executive compensation and ratified Ernst & Young LLP as the independent auditor. Shareholder proposals for an independent board chair and an annual lobbying report were not approved.